Piramal Pharma Limited
PPLPHARMA

Piramal Pharma Limited

Pharmaceuticals
Share price
₹239
Market cap
₹31,853 Cr
1Y return
▲ 26%

A pharmaceutical company operating across three major segments: contract development and manufacturing organisations, complex hospital generics for critical care, and consumer healthcare products. Established through the acquisition of Nicholas Laboratories in 1988, the company has expanded via strategic mergers and acquisitions alongside organic growth initiatives. It serves healthcare providers and consumers across India through its diversified business operations and specialized pharmaceutical solutions.

Investors holding Piramal Pharma Limited

HDFC Mutual Fund
HDFC Mutual Fund
Mutual Fund
5.65%
EB
East Bridge Capital
Foreign Investor
2.00%
1.56%

Recent moves 6

1move in the last 30 days
Members only
Unlock this move
Nippon India Mutual FundNew position
Nippon India Mutual Fund added over 0.56% of Piramal Pharma and now holds 1.56% of the company, representing 2,07,58,801 shares.
21 Oct 2026
Read more
HDFC Mutual FundDecreased
HDFC Mutual Fund decreased its stake in Piramal Pharma from 7.68% to 5.65%, selling 2,70,61,536 shares.
21 Oct 2026
Read more
Canara Robeco Mutual FundExited
Canara Robeco Mutual Fund, which last reported a 1.0 percent stake in Piramal Pharma Limited, is no longer on the list of disclosed shareholders, indicating either a complete sale or a reduction to below the 1 percent reporting threshold.
19 Jul 2026
Read more
HDFC Mutual FundDecreased
HDFC Mutual Fund decreased its stake in Piramal Pharma Limited from 9.37% to 7.68%, selling 22,260,933 shares.
17 Jul 2026
Read more
HDFC Mutual FundDecreased
HDFC Mutual Fund decreased its stake in Piramal Pharma from 9.02% to 7.01%, selling 2,66,88,471 shares via open market on July 14, 2026.
14 Jul 2026
Read more

Track the whales in Piramal Pharma Limited

Get alerted the moment a top investor buys or sells.

Start 7 days for ₹1